Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results